Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,891
Total Claims
$541K
Drug Cost
333
Beneficiaries
$1,626
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+44%
Cost per patient vs peers
$1,626 vs $1,128 avg
+67%
Brand preference vs peers
14.0% vs 8.4% avg
Brand vs Generic
Brand: 1,640 claims · $423K
Generic: 10,049 claims · $114K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 79 | $44K |
| Dulaglutide | 41 | $39K |
| Rivaroxaban | 53 | $35K |
| Levothyroxine Sodium | 499 | $30K |
| Linagliptin | 34 | $25K |
| Dapagliflozin Propanediol | 34 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $21K |
| Insulin Nph Human Isophane | 71 | $21K |
| Budesonide/Formoterol Fumarate | 44 | $17K |
| Insulin Nph Hum/Reg Insulin Hm | 55 | $17K |
| Lamotrigine | 12 | $15K |
| Empagliflozin | 16 | $13K |
| Fluticasone/Umeclidin/Vilanter | 17 | $11K |
| Ticagrelor | 16 | $11K |
| Linagliptin/Metformin Hcl | 17 | $9,355 |
Prescribing Profile
Patient Profile
69
Avg Age
66%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data